Moderator: Keo Samley

• Prevention of hepatitis B and D (including PMTCT- increasing HBV birth dose, novel strategies to treat any woman HbsAg+ if no HBV DNA or birth dose available) Ben Cowie 
• Prevention of hepatitis C (focus on PWID – known interventions that are effective, such as opioid agonist treatment and syringe service programs) Julie Bruneau
• Oral Presentation: MODELING THE EFFECT OF TARGETED INTERVENTIONS ON THE SPREAD OF HEPATITIS C THROUGH A NETWORK OF PEOPLE WHO INJECT DRUGS IN KENYA Ewan Colman
• Oral Presentation: OPTIMIZING TESTING AND TREATMENT STRATEGIES FOR HEPATITIS C ELIMINATION IN PUNJAB, PAKISTAN; REPORT FROM HEPATITIS PREVENTION AND TREATMENT PROGRAM Saeed Akhter
• Oral Presentation: IMPACT OF A TREATMENT PEER-SUPPORT MODEL ON HEPATITIS B SCREENING AND LINKAGE TO INTEGRATED HIV/HBV CARE IN A HIGH BURDEN HBV SETTING IN NORTHERN UGANDA Joan J. Mutyoba
• Oral Presentation: CHARACTERIZING ENGAGEMENT IN HEPATITIS C VIRUS TESTING AND CARE FOR INFANTS BORN TO PERSONS WHO TEST POSITIVE FOR HCV IN ONTARIO, CANADA Andrew B. Mendlowitz
• Q&A